# DUSA Pharmaceuticals, Inc. – FDA Inspection, Mar 4, 2010

Source: https://www.keypedia.com/records/fda_inspections/dusa-pharmaceuticals-inc/86179c65-85f8-4949-bdd8-212d4c125fa5
Source feed: FDA_Inspections

> FDA inspection 649444 of DUSA Pharmaceuticals, Inc., March 04, 2010. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 649444
- Company Name: DUSA Pharmaceuticals, Inc.
- Inspection Date: 2010-03-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1217179 - 2023-09-08](https://www.keypedia.com/records/fda_inspections/dusa-pharmaceuticals-inc/473e61bf-5426-48c4-a8a0-9785e8266127)
- FDA Inspection 986674 - 2016-09-22
- FDA Inspection 934706 - 2015-05-29
- [FDA Inspection 788414 - 2012-06-20](https://www.keypedia.com/records/fda_inspections/dusa-pharmaceuticals-inc/7c7cb1ec-2fb2-43a7-af20-0e7060e3d401)
- FDA Inspection 777605 - 2012-04-18

Company: https://www.keypedia.com/companies/dusa-pharmaceuticals-inc/477fe89d-b607-4aae-82b5-23a02cca9bd0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c